These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 18042110

  • 1. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
    Turner D, Grossman AB, Rosh J, Kugathasan S, Gilman AR, Baldassano R, Griffiths AM.
    Am J Gastroenterol; 2007 Dec; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y.
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 5. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 6. A single-center experience with methotrexate after thiopurine therapy in pediatric Crohn disease.
    Boyle B, Mackner L, Ross C, Moses J, Kumar S, Crandall W.
    J Pediatr Gastroenterol Nutr; 2010 Dec 15; 51(6):714-7. PubMed ID: 20706154
    [Abstract] [Full Text] [Related]

  • 7. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.
    Am J Gastroenterol; 2004 May 15; 99(5):878-83. PubMed ID: 15128354
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
    Arora S, Katkov W, Cooley J, Kemp JA, Johnston DE, Schapiro RH, Podolsky D.
    Hepatogastroenterology; 1999 May 15; 46(27):1724-9. PubMed ID: 10430331
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
    Suares NC, Hamlin PJ, Greer DP, Warren L, Clark T, Ford AC.
    Aliment Pharmacol Ther; 2012 Jan 15; 35(2):284-91. PubMed ID: 22112005
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G, Israel DM, Hassall E.
    Am J Gastroenterol; 1996 Jul 15; 91(7):1355-9. PubMed ID: 8677994
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
    Lémann M, Zenjari T, Bouhnik Y, Cosnes J, Mesnard B, Rambaud JC, Modigliani R, Cortot A, Colombel JF.
    Am J Gastroenterol; 2000 Jul 15; 95(7):1730-4. PubMed ID: 10925976
    [Abstract] [Full Text] [Related]

  • 12. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct 15; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):614-20. PubMed ID: 19552632
    [Abstract] [Full Text] [Related]

  • 14. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov 15; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]

  • 15. Role of methotrexate in the management of Crohn disease.
    Ravikumara M, Hinsberger A, Spray CH.
    J Pediatr Gastroenterol Nutr; 2007 Apr 15; 44(4):427-30. PubMed ID: 17414138
    [Abstract] [Full Text] [Related]

  • 16. The safety and tolerability of methotrexate for treating patients with Crohn's disease.
    Chande N, Abdelgadir I, Gregor J.
    J Clin Gastroenterol; 2011 Aug 15; 45(7):599-601. PubMed ID: 21224737
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF.
    Rev Gastroenterol Disord; 2003 Aug 15; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [Abstract] [Full Text] [Related]

  • 18. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P, Reinisch W, Ho E, Gratzer C, Lissner D, Herkner H, Riss S, Dejaco C, Miehsler W, Vogelsang H, Novacek G.
    Am J Gastroenterol; 2010 May 15; 105(5):1158-64. PubMed ID: 20010925
    [Abstract] [Full Text] [Related]

  • 19. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
    Navarro FA, Hanauer SB, Kirschner BS.
    J Pediatr Gastroenterol Nutr; 2007 Sep 15; 45(3):312-8. PubMed ID: 17873743
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate: first-line or second-line immunomodulator?
    Fraser AG.
    Eur J Gastroenterol Hepatol; 2003 Mar 15; 15(3):225-31. PubMed ID: 12610315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.